ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Aminah Jatoi
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jatoi, A.
Right arrow Articles by Roubenoff, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jatoi, A.
Right arrow Articles by Roubenoff, R.
Related Collections
Right arrow Lung - cancer

Ann Thorac Surg 2001;72:348-351
© 2001 The Society of Thoracic Surgeons


Original article: general thoracic

Do patients with nonmetastatic non-small cell lung cancer demonstrate altered resting energy expenditure?

Aminah Jatoi, MDa,b, Benedict D.T. Daly, MDc, Virginia A. Hughes, MSd, Gerard E. Dallal, PhDe, Joseph Kehayias, PhDf, Ronenn Roubenoff, MD, MHSa,d

a Division of Clinical Nutrition, The New England Medical Center, Tufts University, Boston, Massachusetts, USA
b Division of Hematology/Oncology, Department of Medicine, The New England Medical Center, Tufts University, Boston, Massachusetts, USA
c Division of Cardiothoracic Surgery, Department of Surgery, The New England Medical Center, Tufts University, Boston, Massachusetts, USA
d Nutrition, Exercise Physiology, and Sarcopenia Laboratory, The Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts, USA
e Biostatistics Section, The Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts, USA
f Body Composition Laboratory, The Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts, USA

Accepted for publication May 14, 2001.

Address reprint requests to Dr Jatoi, Division of Medical Oncology, Mayo Clinic, 200 First St SW, Rochester, MN 55905
e-mail: jatoi.aminah{at}mayo.edu

Background. The cancer cachexia syndrome occurs in patients with non-small cell lung cancer (NSCLC) and includes elevated resting energy expenditure (REE). This increase in REE leads to weight loss, which in turn confers a poor prognosis. This study was undertaken to determine whether the cancer cachexia syndrome occurs in patients with nonmetastatic NSCLC.

Methods. In this case-control study, 18 patients with nonmetastatic NSCLC (stages IA to IIIB) were matched to healthy controls on age (± 5 years), gender, and body mass index (± 3 kg/m2). Only 4 cancer patients had experienced > 5% weight loss. Cancer patients and controls were compared on the basis of: (1) unadjusted REE, as measured by indirect calorimetry; (2) REE adjusted for lean body mass, as measured by dual x-ray absorptiometry; (3) REE adjusted for body cell mass, as measured by potassium-40 measurement; and (4) REE adjusted for total body water, as measured by tritiated water dilution.

Results. We observed no significant difference in unadjusted REE or in REE adjusted for total body water. However, with separate adjustments for lean body mass and body cell mass, cancer patients manifested an increase in REE: mean difference ± standard error of the mean: 140 ± 35 kcal/day (p = 0.001) and 173 ± 65 kcal/day (p = 0.032), respectively. Further adjustment for weight loss yielded similarly significant results.

Conclusions. These results suggest that the cancer cachexia syndrome occurs in patients with nonmetastatic NSCLC and raise the question of whether clinical trials that target cancer cachexia should be initiated before weight loss.




This article has been cited by other articles:


Home page
QJMHome page
J.N. Gordon, S.R. Green, and P.M. Goggin
Cancer cachexia
QJM, November 1, 2005; 98(11): 779 - 788.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
D. H. Esper and W. A. Harb
The Cancer Cachexia Syndrome: A Review of Metabolic and Clinical Manifestations
Nutr Clin Pract, August 1, 2005; 20(4): 369 - 376.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. M. Garcia, M. Garcia-Touza, R. A. Hijazi, G. Taffet, D. Epner, D. Mann, R. G. Smith, G. R. Cunningham, and M. Marcelli
Active Ghrelin Levels and Active to Total Ghrelin Ratio in Cancer-Induced Cachexia
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2920 - 2926.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Dahele and L. Wall
Optimizing End Points and Outcomes in Cancer-Associated Wasting
J. Clin. Oncol., April 20, 2005; 23(12): 2871 - 2872.
[Full Text] [PDF]


Home page
Palliat MedHome page
M. Dahele and K. Fearon
Research methodology: cancer cachexia syndrome
Palliative Medicine, July 1, 2004; 18(5): 409 - 417.
[Abstract] [PDF]


Home page
JCOHome page
A. Jatoi and C. L. Loprinzi
Adenosine Triphosphate: Does It Help Cancer Patients "Get Bigger and Stronger"?
J. Clin. Oncol., January 15, 2002; 20(2): 362 - 363.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 by The Society of Thoracic Surgeons.